Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Atricure (ATRC)
NASDAQ:ATRC
Earnings Data
Report Date
Apr 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.22Last Year’s EPS
-0.28Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 12, 2025
|% Change Since: -7.55%
|Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a strong year for AtriCure with significant revenue growth and improved profitability driven by new product launches and international expansion. However, challenges remain in the hybrid AF therapy segment in the U.S. and gross margin declines due to unfavorable mix. The outlook for 2025 is positive, with growth expected to continue, albeit with some pressures in specific segments.Company Guidance
During AtriCure's Fourth Quarter and Full Year 2024 Earnings Conference Call, the company provided detailed guidance for 2025, projecting revenue between $517 million and $527 million, representing an 11% to 13% growth over 2024. The adjusted EBITDA is expected to increase significantly by nearly 40%, ranging from $42 million to $44 million. For 2024, AtriCure reported a revenue of $465 million, with a 17% growth, and expanded their adjusted EBITDA from $19 million in 2023 to $31 million in 2024. The call highlighted robust growth in various franchises, including a 32% increase in the pain management franchise and a 16% rise in the open franchise. The company also announced significant advancements, including new product launches and progress in clinical trials, with a focus on driving long-term growth and profitability.Impressive Revenue Growth
AtriCure achieved revenue of $465 million in 2024, representing a 17% growth year-over-year, driven by strong performance in pain management, open appendage management, and open ablation franchises.
Increased Profitability
Full year adjusted EBITDA expanded from $19 million in 2023 to $31 million in 2024, showing a significant improvement in profitability.
Strong Performance in Pain Management
The pain management franchise grew 32% worldwide in 2024 and 43% in the fourth quarter, bolstered by new product launches like cryoSPHERE+ and cryoSPHERE MAX probe.
Successful Product Launches
Launches of EnCompass Clamp in Europe and AtriClip FLEX-Mini in the U.S. contributed to growth in respective segments, with positive feedback received.
International Revenue Growth
International revenue increased by 27.7% on a reported basis and 28.1% on a constant currency basis in Q4 2024, showcasing strong demand across major international markets.
Strong Financial Outlook for 2025
AtriCure reaffirmed its 2025 revenue guidance of $517 million to $527 million, with expected adjusted EBITDA to range from $42 million to $44 million, indicating continued growth and profitability.
Expansion into New Markets
Approval for AtriClip devices in China and expanded indications in CE-Mark countries position AtriCure for future growth in new geographic and clinical markets.
---
ATRC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ATRC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 12, 2025 | $42.36 | $39.59 | -6.54% |
| Oct 29, 2024 | $29.43 | $34.83 | +18.35% |
| Jul 30, 2024 | $22.00 | $21.57 | -1.95% |
| May 01, 2024 | $24.76 | $22.22 | -10.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Atricure (ATRC) report earnings?
Atricure (ATRC) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
What is Atricure (ATRC) earnings time?
Atricure (ATRC) earnings time is at Apr 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ATRC EPS forecast?
ATRC EPS forecast for the fiscal quarter 2025 (Q1) is -0.22.
---